# Zenith® TXD Post-market Surveillance in Japan

> **NCT02663739** · — · COMPLETED · sponsor: **Cook Group Incorporated** · enrollment: 57 (actual)

## Conditions studied

- Aortic Dissection

## Interventions

- **DEVICE:** Zenith® TXD

## Key facts

- **NCT ID:** NCT02663739
- **Lead sponsor:** Cook Group Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2023-03-28
- **Final completion:** 2023-03-28
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02663739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02663739, "Zenith® TXD Post-market Surveillance in Japan". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT02663739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*